Your browser doesn't support javascript.
loading
Measurement of Tumor Hypoxia in Patients With Locally Advanced Cervical Cancer Using Positron Emission Tomography with 18F-Fluoroazomyin Arabinoside.
Han, Kathy; Shek, Tina; Vines, Douglass; Driscoll, Brandon; Fyles, Anthony; Jaffray, David; Keller, Harald; Metser, Ur; Pintilie, Melania; Xie, Jason; Yeung, Ivan; Milosevic, Michael.
Afiliação
  • Han K; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada. Electronic address: Kathy.Han@rmp.uhn.ca.
  • Shek T; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Quantitative Imaging for Personalized Cancer Medicine, Techna Institute, University Health Network, Toronto, Ontario, Canada.
  • Vines D; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada; Quantitative Imaging for Personalized Cancer Medicine, Techna Institute, University Health Network, Tor
  • Driscoll B; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Quantitative Imaging for Personalized Cancer Medicine, Techna Institute, University Health Network, Toronto, Ontario, Canada.
  • Fyles A; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
  • Jaffray D; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada; Quantitative Imaging for Personalized Cancer Medicine, Techna Institute, University Health Network, Tor
  • Keller H; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada; Quantitative Imaging for Personalized Cancer Medicine, Techna Institute, University Health Network, Tor
  • Metser U; Joint Department of Medical Imaging, University Health Network, Toronto, Ontario, Canada; Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada.
  • Pintilie M; Department of Biostatistics, University Health Network, Toronto, Ontario, Canada.
  • Xie J; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Yeung I; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada; Quantitative Imaging for Personalized Cancer Medicine, Techna Institute, University Health Network, Tor
  • Milosevic M; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
Int J Radiat Oncol Biol Phys ; 102(4): 1202-1209, 2018 11 15.
Article em En | MEDLINE | ID: mdl-29680257

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioisótopos de Flúor / Neoplasias do Colo do Útero / Compostos Radiofarmacêuticos / Tomografia por Emissão de Pósitrons / Hipóxia Tumoral / Nitroimidazóis Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioisótopos de Flúor / Neoplasias do Colo do Útero / Compostos Radiofarmacêuticos / Tomografia por Emissão de Pósitrons / Hipóxia Tumoral / Nitroimidazóis Idioma: En Ano de publicação: 2018 Tipo de documento: Article